Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu (Q46668706)
scientific article published in July 2005
Language:
Current Data About Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu
(P31) (Q13442814)
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P50) (Q88893122)
(P1545) 2
(P1932) Bernhard Meyer
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(Q45343075)
(P1545) 1
(P1932) Peter Vajkoczy
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(Q103780680)
(P1545) 6
(P1932) Florian Ringel
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P304) 9-17
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P407) (Q1860)

(P433) 1
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P478) 103
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P577) Friday, July 1, 2005
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P921) (Q269829)
(P887)

(Q108323719)
(P887)

(P1433) (Q15708886)
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P1476) "Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa stu" (language: en)
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

(P2093) Stefan Weidauer
(P1545) 3
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

Andreas Raabe
(P1545) 4
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

Claudius Thome
(P1545) 5
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

Volker Breu
(P1545) 7
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

Peter Schmiedek
(P1545) 8
(P248)
(P698) 16121967
(P813) Sunday, December 24, 2017
(P854) http://europepmc.org/abstract/MED/16121967

other details
description scientific article published in July 2005

External Links
(P356) 10.3171/JNS.2005.103.1.0009
(P698) 16121967